Company

Coherus Oncology

Biotechnology Research Redwood City, California, United States 240 employees ARQT

Employees: 240
Contacts: 2
Emails: 2

www.coherus.com LinkedIn Crunchbase

Coherus Oncology Overview

Headquarters: Redwood City, California, United States
Website: www.coherus.com
Industry: Biotechnology Research
Employees: 240
Founded: 2010
Stock Symbol: ARQT
Funding: 50.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

biotechnology and Immuno-oncology

About Coherus Oncology

Coherus Oncology is a fully integrated commercial-stage innovative oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a promising pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Our strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both our pipeline candidates as well as our industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities.

Coherus Oncology Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

Coherus Oncology Org Chart

Sample employees and titles

Name	Title	Location	Contact
Tammy Booth	Manager, Recruiting at Coherus		View
Ali Satvat			View
Ron Miller	Executive Director, Pricing	New York City Metropolitan Area, United States	Email
Bryan Mcmichael	CFO	Pacifica, California, United States	Email